Boardroom Alpha
10-Q primary document
HROW · Quarterly Report (Form 10-Q) · Filed November 10, 2025

Harrow Inc10-Q exhibit

ex10-1.htm

 

Exhibit 10.1

 

   

1A Burton Hills Blvd

Nashville TN 37215

 

Main: 858.704.4040

Fax: 858.345.1745

www.harrowinc.com

 

August 14, 2025

 

Dear Randy:

 

We are pleased to extend the offer of employment (the “Offer Letter”) to you to serve as the Chief Accounting Officer at Harrow, Inc. (hereinafter, “Harrow”), reporting to Andrew Boll, President & CFO. Your target start date will be September [1], 2025. Your annual compensation will be $400,000. This is a full-time, exempt-level position with an annual discretionary target bonus of 40% of your salary (the “Target Bonus Amount”), earned during the year, and paid at a time consistent with other bonus payments made to senior Harrow leadership (the “Day of Payment”). While no bonus payment (a “Bonus Payment”) is guaranteed, your potential annual discretionary Target Bonus Amount will be based on the achievement of targets agreed upon by you and Mr. Boll. You must be employed with Harrow on the Day of Payment to receive a Bonus Payment of the Target Bonus Amount. In addition, Harrow will cover up to $20,000 in relocation expenses. If you leave the company within a year, you will be responsible for reimbursing relocation funds paid out. Upon completing 12 months of service to Harrow as its Chief Accounting Officer, if Harrow terminates your employment without cause, Harrow will pay you 6 months of base compensation through the normal course of payroll schedule (the “Involuntary Severance Payment”).

 

Subject to the approval of the Compensation Committee of the Harrow Board of Directors, you will be granted a stock option to purchase 30,000 shares of Harrow common stock subject to the terms of Harrow’s equity incentive award plan. These options will have an exercise price per share equal to the fair market value of the Harrow common stock as of the date of grant (e.g., following Harrow Board of Directors approval), and shall vest over a four-year period, with 25% vesting on the one-year anniversary of its grant and in equal quarterly installments thereafter, subject to your continued service as further described in the stock option agreement.

 

Based on your performance, other reasonable metrics, and factors determined by the Board of Directors, you may become eligible for additional equity awards in the future. Harrow has an excellent benefits program, including comprehensive medical, dental, and vision plans. You will be eligible to participate in our medical, dental, and vision plans on the first of the month following the first day of employment. In addition, you will have a 20-day/160 hours personal time off (PTO) account, which accrues bi-weekly. You are eligible to participate in our 401(k) plan if you are 21 years of age or older and following six months of employment and 500 hours of work. In addition, you will be entitled to indemnification in accordance with Harrow’s policies and applicable law, and Harrow will include you in coverage under any applicable director and officer insurance policy maintained by Harrow for its executive officers and management.

 

If you intend to accept the terms of this Offer Letter, please sign in the space indicated below, and return it to us no later than Aug 18, 2025. This Offer Letter sets forth our entire agreement and understanding regarding the terms of your employment with Harrow and supersedes all prior or contemporaneous agreements, understandings, negotiations, or representations, whether oral or written, expressed or implied, on this subject. This Offer Letter may not be modified or amended except by a specific, written agreement signed by you and an authorized representative of Harrow.

 

Page 1 of 2
 

 

   

1A Burton Hills Blvd

Nashville TN 37215

 

Main: 858.704.4040

Fax: 858.345.1745

www.harrowinc.com

 

Your offer and employment are contingent upon:

 

  Signing and abiding by the Company’s Confidentiality Agreement, Arbitration Agreement, and the Proprietary Information and Inventions Assignment Agreement.
     
  You also must establish your identity and authorization to work as required by the Immigration Reform and Control Act of 1986 (IRCA); Please bring the appropriate original documentation on your first day of work.
     
  Successful completion of a routine background check by an outside agency.
     
  Successful passage of a drug screening test.
     
  Licensing or certification requirements.
     
  Acceptance of other company policies and procedures, including, but not limited to, our Employee Manual, Code of Business Conduct and Ethics, and Insider Trading Policy.

 

Your employment with Harrow will be at will. This means you may resign at any time and for any reason. Likewise, Harrow may terminate the employment relationship at any time, with or without cause or advanced notice. In addition, Harrow reserves the right to modify your position, duties, and/or reporting relationship to meet business needs and to use its discretion in deciding on appropriate discipline. Any change to the at-will employment relationship must be by a specific, written agreement, signed by you and Harrow.

 

We hope your employment with Harrow will prove mutually rewarding.

 

Sincerely,

 

Mark L. Baum

Chairman & CEO

 

*         *           *

 

/s/ Mark L. Baum  
Signature Date  

 

I have read this agreement in its entirety and agree to the terms and conditions of employment described in these documents. I understand and agree that my employment with Harrow is at-will. Your employment relationship with Harrow will be subject to the terms and conditions of this Offer Letter.

 

8/14/2025   /s/ Randy Pollard
Date   Randy Pollard

 

Page 2 of 2

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer